Here you will find insights from our team and contributions from leading biotech entrepreneurs. We plan to feature a mix of articles, thoughts and commentary around our investments, as well as news and trends in the biotech industry.
9th November 2020
Arix’s first M&A exit: VelosBio to be acquired by Merck for $2.75bn in cash
8th July 2020
VelosBio closes $137m Series B
5th May 2020
Amplyx CEO on COVID-19 and Fungal Superinfections
20th June 2019
'EU Gives Lynparza Green Light as First-Line Ovarian Cancer Treatment' - Artios CEO interviewed by Labiotech